There are several trials on prevention of diabetes with TZDs.
几项临床试验开展了噻唑烷二酮类药物预防糖尿病的研究。
Men with diabetes taking both loop diuretics and TZDs may also be at increased risk of fractures, according to the research.
依照这一研究，患有糖尿病的男性在同时服用髓袢利尿药和噻唑烷二酮类药物时也会增加骨折的危险。
Thiazolidinediones (TZDs) are a new class of agents commonly used for the treatment of patients with type 2 diabetes or insulin resistance.
噻唑烷二酮类药物是一类新的治疗2型糖尿病和胰岛素抵抗的药物。
CONCLUSION: Postmenopausal women taking TZDs and the subset of men taking both loop diuretics and TZDs were at increased risk for fractures.
结论：绝经后女性服用TZD与男性同时服用髓袢利尿剂和TZD骨折风险均增加。
For more than 10 years, thiazolidinediones (TZDs) have been prescribed for diabetes therapy in the U. S. on the sole basis of evidence that they improve glycemic control.
在美国，基于噻唑啉二酮类药物能提高人体控制血糖的能力，10多年来该药物一直用于糖尿病的治疗。
A new study has revealed that postmenopausal women with diabetes taking thiazolidinediones (TZDS), including rosiglitazone and pioglitazone, may be at increased risk for fractures.
一项新的研究显示患有糖尿病的绝经妇女在服用噻唑烷二酮类药物，包括匹格列酮与罗格列酮时，会增加骨折的危险。
A new study has revealed that postmenopausal women with diabetes taking thiazolidinediones (TZDS), including rosiglitazone and pioglitazone, may be at increased risk for fractures.
一项新的研究显示患有糖尿病的绝经妇女在服用噻唑烷二酮类药物，包括匹格列酮与罗格列酮时，会增加骨折的危险。
应用推荐